Correlation Between Allarity Therapeutics and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Neoleukin Therapeutics, you can compare the effects of market volatilities on Allarity Therapeutics and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Neoleukin Therapeutics.
Diversification Opportunities for Allarity Therapeutics and Neoleukin Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Allarity and Neoleukin is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and Neoleukin Therapeutics
Given the investment horizon of 90 days Allarity Therapeutics is expected to under-perform the Neoleukin Therapeutics. In addition to that, Allarity Therapeutics is 1.53 times more volatile than Neoleukin Therapeutics. It trades about -0.26 of its total potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest 78.00 in Neoleukin Therapeutics on September 1, 2024 and sell it today you would lose (9.00) from holding Neoleukin Therapeutics or give up 11.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 8.33% |
| Values | Daily Returns |
Allarity Therapeutics vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Allarity Therapeutics |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Allarity Therapeutics and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allarity Therapeutics and Neoleukin Therapeutics
The main advantage of trading using opposite Allarity Therapeutics and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |